These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9708349)

  • 1. Biologically active oligodeoxyribonucleotides. 10: anti-HIV-1 activity and stability of modified hexanucleotides containing glycerol-skeleton.
    Hotoda H; Koizumi M; Ohmine T; Furukawa H; Nishigaki T; Abe K; Kosaka T; Tsutsumi S; Sone J; Kaneko M
    Nucleosides Nucleotides; 1998; 17(1-3):243-52. PubMed ID: 9708349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologically active oligodeoxyribonucleotides. Part 12: N2-methylation of 2'-deoxyguanosines enhances stability of parallel G-quadruplex and anti-HIV-1 activity.
    Koizumi M; Akahori K; Ohmine T; Tsutsumi S; Sone J; Kosaka T; Kaneko M; Kimura S; Shimada K
    Bioorg Med Chem Lett; 2000 Oct; 10(19):2213-6. PubMed ID: 11012032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologically active oligodeoxyribonucleotides. Part 11: The least phosphate-modification of quadruplex-forming hexadeoxyribonucleotide TGGGAG, bearing 3-and 5-end-modification, with anti-HIV-1 activity.
    Koizumi M; Koga R; Hotoda H; Ohmine T; Furukawa H; Agatsuma T; Nishigaki T; Abe K; Kosaka T; Tsutsumi S; Sone J; Kaneko M; Kimura S; Shimada K
    Bioorg Med Chem; 1998 Dec; 6(12):2469-75. PubMed ID: 9925303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologically active oligodeoxyribonucleotides--IX. Synthesis and anti-HIV-1 activity of hexadeoxyribonucleotides, TGGGAG, bearing 3'- and 5'-end-modification.
    Koizumi M; Koga R; Hotoda H; Momota K; Ohmine T; Furukawa H; Agatsuma T; Nishigaki T; Abe K; Kosaka T; Tsutsumi S; Sone J; Kaneko M; Kimura S; Shimada K
    Bioorg Med Chem; 1997 Dec; 5(12):2235-43. PubMed ID: 9459021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologically active oligodeoxyribonucleotides. 5. 5'-End-substituted d(TGGGAG) possesses anti-human immunodeficiency virus type 1 activity by forming a G-quadruplex structure.
    Hotoda H; Koizumi M; Koga R; Kaneko M; Momota K; Ohmine T; Furukawa H; Agatsuma T; Nishigaki T; Sone J; Tsutsumi S; Kosaka T; Abe K; Kimura S; Shimada K
    J Med Chem; 1998 Sep; 41(19):3655-63. PubMed ID: 9733490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and anti-HIV activity of phosphorothioate antisense DNA containing C-5 polyamine substituted 2'-deoxyuridine and/or acridine residues.
    Shinozuka K; Okamoto T; Matsukura M; Sawai H
    Nucleic Acids Symp Ser; 1997; (37):215-6. PubMed ID: 9586076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How a modification (8-aza-3-deaza-2'-deoxyguanosine) influences the quadruplex structure of Hotoda's 6-mer TGGGAG with 5'- and 3'-end modifications.
    Jaksa S; Kralj B; Pannecouque C; Balzarini J; De Clercq E; Kobe J
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):77-88. PubMed ID: 15043138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorothioate analogues of oligodeoxyribonucleotide: synthesis and activity as inhibitors of replication of human immunodeficiency virus.
    Kim SG; Suzuki Y; Nakashima H; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1614-9. PubMed ID: 1930201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ether phospholipid-AZT conjugates possessing anti-HIV and antitumor cell activity. Synthesis, conformational analysis, and study of their thermal effects on membrane bilayers.
    Mavromoustakos T; Calogeropoulou T; Koufaki M; Kolocouris A; Daliani I; Demetzos C; Meng Z; Makriyannis A; Balzarini J; De Clercq E
    J Med Chem; 2001 May; 44(11):1702-9. PubMed ID: 11356105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cordycepin analogue of 2,5A and its threo isomer. Chemical synthesis, conformation and biological activity.
    Nyilas A; Vrang L; Drake A; Oberg B; Chattopadhyaya J
    Acta Chem Scand B; 1986 Sep; 40(8):678-88. PubMed ID: 3825401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HIV activity of new higher order G-quadruplex aptamers obtained from tetra-end-linked oligonucleotides.
    Nici F; Oliviero G; Falanga AP; D'Errico S; Marzano M; Musumeci D; Montesarchio D; Noppen S; Pannecouque C; Piccialli G; Borbone N
    Org Biomol Chem; 2018 Mar; 16(13):2349-2355. PubMed ID: 29543291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azadideoxyadenosine: synthesis, enzymology, and anti-HIV activity.
    Nishonov AA; Ma X; Nair V
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4099-101. PubMed ID: 16698265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship in the 3-iodo-4-phenoxypyridinone (IOPY) series: The nature of the C-3 substituent on anti-HIV activity.
    Benjahad A; Oumouch S; Guillemont J; Pasquier E; Mabire D; Andries K; Nguyen CH; Grierson DS
    Bioorg Med Chem Lett; 2007 Feb; 17(3):712-6. PubMed ID: 17157017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric synthesis and anti-HIV activity of L-carbocyclic 2',3'-didehydro-2',3'-dideoxyadenosine.
    Wang P; Schinazi RF; Chu CK
    Bioorg Med Chem Lett; 1998 Jul; 8(13):1585-8. PubMed ID: 9873395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of a highly active new anti-HIV agent 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine.
    Haraguchi K; Takeda S; Tanaka H; Nitanda T; Baba M; Dutschman GE; Cheng YC
    Bioorg Med Chem Lett; 2003 Nov; 13(21):3775-7. PubMed ID: 14552777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anti-HIV activity of different novel nonclassical nucleosides.
    Elgemeie GE; Mansour OA; Metwally NH
    Nucleosides Nucleotides; 1999 Jan; 18(1):113-23. PubMed ID: 10048227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorothioate and cordycepin analogues of 2',5'-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitro.
    Montefiori DC; Sobol RW; Li SW; Reichenbach NL; Suhadolnik RJ; Charubala R; Pfleiderer W; Modliszewski A; Robinson WE; Mitchell WM
    Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7191-4. PubMed ID: 2476814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer molecule AS1411 exhibits low nanomolar antiviral activity against HIV-1.
    Métifiot M; Amrane S; Mergny JL; Andreola ML
    Biochimie; 2015 Nov; 118():173-5. PubMed ID: 26363100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biophysical characterization, and anti-HIV activity of glyco-conjugated G-quadruplex-forming oligonucleotides.
    D'Onofrio J; Petraccone L; Martino L; Di Fabio G; Iadonisi A; Balzarini J; Giancola C; Montesarchio D
    Bioconjug Chem; 2008 Mar; 19(3):607-16. PubMed ID: 18254584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320).
    Buckheit RW; Roberson JL; Lackman-Smith C; Wyatt JR; Vickers TA; Ecker DJ
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1497-506. PubMed ID: 7888204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.